Advancing the Cardiovascular Care of the Oncology Patient

Advancing the Cardiovascular Care of the Oncology Patient

COURSE OVERVIEW/STATEMENT OF NEED
Cardiovascular disease is the second leading cause of morbidity and mortality in cancer survivors. Since an estimated 14.5 million cancer patients and survivors have significant cardiovascular risk factors, it is critical for cardiologists, oncologists, and the entire multi-professional care team to stay on the leading edge of this rapidly evolving field. Advancing the Cardiovascular Care of the Oncology Patient provides clinicians and researchers with the tools needed to improve patient care in your everyday practice.

Over the past 4 years, the American College of Cardiology has joined forces with respected experts in the field of Cardio-oncology to develop a program covering the most relevant and required content for both the novice and advancing practitioner. Join us at Advancing the Cardiovascular Care of the Oncology Patient and engage with our growing community. Participate through interactive case discussions on evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health. Throughout the course, you'll have the unique opportunity to engage with expert faculty and a network of colleagues centered around ensuring your patients receive the most informed care possible.

Goal
The overall goal of this course is to provide clinically relevant, state-of-the-art, best practice strategies for the interprofessional team in the assessment, diagnosis and management of cardiovascular concerns for patients with cancer and/or those requiring survivorship care.

Learning Objectives
Upon completion of this course, learners should be able to —

  • Discuss the mechanisms of action as it relates to both oncologic efficacy and cardiotoxicity of common cancer treatment therapies and the resultant impact on cardiovascular disease
  • Review the appropriate imaging modalities to assess cardiotoxicity, distinguish the strengths and weaknesses of the respective modalities available, and the optimal approach to long term surveillance
  • Summarize guidelines from the cardiology and oncology societies for risk stratification, monitoring strategies, and management, and identify action steps to incorporate guidance into clinical practice
  • Evaluate best practices for understanding coronary disease, vascular toxicities – including hypertension and peripheral arterial disease, and bleeding/thrombosis in cancer patients
  • Analyze the short and long-term surveillance and management plans critical for patients who have received high-risk systemic therapies, including androgen deprivation therapy, thoracic radiation therapy and anthracyclines
  • Identify best practices for developing cardio-oncology service lines and building the inter-professional cardio-oncology team needed for success
  • Recognize the pathologic basis for amyloid, diagnostic workup and also treatment strategies

Target Audience
The target audience is cardiovascular specialists, oncologists, internists, and all members of the multi-professional care team (including advanced practice providers, pharmacists, nurses) who are providing clinical care to the growing population of cancer patients and survivors with cardiovascular concerns.

Course Directors

Ana Barac, MD, PhD, FACC
Medstar Washington Hospital Center

Bonnie Ky, MD, MSCE, FACC
University of Pennsylvania School of Medicine

Planning Committee

Rachel Barish, MSN, ANP-BC, AACC
Medstar Georgetown Physicians Group

Christine Cambareri, PharmD, BCPS, BCOP
Hospital of the University of Pennsylvania

Nurse Planner

Chris Keenan, RN, MSN
American College of Cardiology

Keynote Speaker

Richard J. Kovacs, MD, FACC
President, American College of Cardiology

Faculty

Saro Armenian, DO, MPH
City of Hope Comprehensive Cancer Center

Anita Arnold, DO, FACC, FSCAI, MBA
Lee Health Systems

Sherry-Ann Brown, MD, PhD, FACC

Jean-Bernard Durand, MD, FACC, FCCP, FHFSA, FAHA
University of Texas

Steven Joel Feigenberg, MD
Hospital of the University of Pennsylvania

Michael Fradley, MD
University of South Florida

Daniel J. Lenihan, MD, FACC
Washington University School of Medicine in St. Louis

Filipa Lynce, MD
Georgetown University

Chiara Melloni, MD, MHS, FACC
Duke University

Iskra Pusic, MD, MSCI
Washington University School of Medicine

Diego Sadler, MD, FACC
Cardiology Associates of West Palm Beach

Mohammad Shahsahebi, MD
Duke University

Paaladinesh Thavendiranathan, MD
Institute of Medical Science
University of Toronto

Ronald Witteles, MD, FACC
Stanford University School of Medicine

Case Presenters

Shiying Liu, MD
University of Toronto

Allison Padegimas, MD
University of Pennsylvania

Han Zhu, MD
Stanford University

Faculty are subject to change without notice.

CONFLICT OF INTEREST (COI) POLICY/DISCLOSURES
ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.

In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
The ACCF designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses
The ACCF designates this educational activity for a maximum of 17 continuing nursing education contact hours (9.25 CNE pharmacotherapeutic contact hours).

Pharmacists
ACCF designates this continuing education activity for 9.25 contact hours (0.925 CEUs) of the Accreditation Council for Pharmacy Education.

While offering the credits noted above, this program is not intended to provide extensive training or certification in the field.

Abstract
Category
Control #Primary Author
First Name
Primary Author
Last Name
Abstract TitleDownloads
Clinical Science 2 Isabela Bispo Costa Evaluation cardiac magnetic resonance imaging in detection of cardiotoxicity in patient with lymphoma treated with anthracyclines Abstract
Poster
ACC Cardio-Oncology Section 3 Diego Sadler American College of Cardiology Multi-state Chapter Cardio-Oncology Network to Improve Physician Participation, Awareness and Education in Cardio Oncology Abstract
Poster
Case Challenge 5 Ricardo De Castro 5 fluorouracil induced coronary thrombosis Abstract
Poster
Case Challenge 7 Ahmed Khalil Right Atrial Mass: Finding the Culprit Abstract
Poster
Case Challenge 8 Brandy Patterson Pericardial Effusion with Tamponade Secondary to Graft Versus Host Disease after Hematopoietic Stem Cell Transplant Abstract
Poster
Case Challenge 9 Tushar Tarun Grade 4 Infusion Reaction Causing Stress Cardiomyopathy and Cardiac Arrest with Daratumumab: A Rare Case Presentation Abstract
Poster
Case Challenge 10 David Dundua Non Anthracycline Cardio-toxicity in a Patient with Mediastinal Sarcoma Abstract
Poster
Case Challenge 11 Ilana Schlam Challenges in Diagnosis of Cardiac Masses: Importance of Cardiac Imaging and Biopsy to Guide Treatment Abstract
Poster
Case Challenge 12 Carolyn Wu The Importance of Tissue Diagnosis – A Case of Positron Emission Tomography-Positive Cardiac Mass Mimicking a Cardiac Malignancy Abstract
Poster
Case Challenge 15 Andres G. Griborio-Guzman Large Echogenic Right Atrium Masses in a Patient with Breast Invasive Ductal Carcinoma and Positive Lymph Nodes undergoing Adjuvant Chemotherapy Abstract
Poster
Case Challenge 16 Andres G. Griborio-Guzman Severe Three-Vessel Disease with Inducible Ischemia in a Patient with Metastatic Serous Adenocarcinoma of the Ovaries undergoing Palliative Chemotherapy Abstract
Poster
Case Challenge 17 Han Zhu A Case of Early Immune Checkpoint Inhibitor Myocarditis Detected on Routine Troponin Monitoring Abstract
Poster
Case Challenge 19 Evgeny Shkolnik Chest Pain and Repolarization Abnormalities in a Patient with Coronary Artery Disease, Breast Cancer and Cancer-related Cardiotoxicity Abstract
Poster
Case Challenge 20 Akito Shindo Acute Heart Failure Induced by Ponatinib: A Case of Ponatinib-Induced Cardiomyopathy Accompanied with Acute Coronary Syndrome Abstract
Poster
Case Challenge 21 Roberto Mateos-Gaitan Management of Neuroendocrine Tumor with Carcinoid Heart Disease and Liver Metastases: Multidisciplinary Approach. Abstract
Poster
Case Challenge 22 Melissa Moey Sipuleucel-T Immontherapy-related Cardiomyopathy: A Novel Observation Abstract
Poster
Case Challenge 23 Nadeem Bilani A Multimodal Approach to Evaluate for Cardiac Metastasis in a Case of Non-Small Cell Lung Cancer Abstract
Poster
Case Challenge 24 Isabela Bispo Costa Left Cardiac Intracavitary Metastases from a Primary Thigh Myxofibrosarcoma Associated with Systemic Embolization: Clinical Case Challenge Abstract
Poster
Case Challenge 25 Agnes Kim 5-Fluorouracil Re-Challenge After Cardiotoxicity Abstract
Poster
Case Challenge 26 Isabela Bispo Costa Constrictive Pericarditis Due to Tuberculous Etiology in Active Lymphoproliferative Disease: A Clinical Case Challenge Abstract
Poster
Case Challenge 27 Anantha Sriharsha Madgula Ventricular Tachycardia Storm in a Patient on Ibrutinib for Waldenstrom Macroglobulinemia Abstract
Poster
Case Challenge 28 J. Michael Blair A rare case report: Malignant pleural mesothelioma surgery complicated by isolated right ventricular Takotsubo requiring ECMO support Abstract
Poster
Case Challenge 29 J. Michael Blair Cytoreductive surgery for Mesothelioma complicated by post-operative Takotsubo cardiomyopathy Abstract
Poster
Case Challenge 30 Montserrat Carrillo-Estrada Troponin Elevation during Treatment with Immune Checkpoint Inhibitors Abstract
Poster
Case Challenge 31 Kim-Trang Ho Minimally invasive mitral valve replacement for severe primary mitral regurgitation in a patient with lung neuroendocrine tumor Abstract
Poster
Case Challenge 32 Kim-Trang Ho A unique case of reversible right heart failure Abstract
Poster
Case Challenge 33 Robert Copeland-Halperin Severe Recurrent Pulmonary Arterial Hypertension from Bosutinib Following Dasatinib Induced Pulmonary Toxicity Abstract
Poster
Case Challenge 34 Anantha Sriharsha Madgula Aortic Dissection in a Patient on Axitinib: Fatal Presentation of a Potential Complication Abstract
Poster
Case Challenge 35 Dylan Lopez Trastuzumab: HER2-Positive Savior or Cardiac Nightmare? Abstract
Poster
Case Challenge 36 Vijay Rao Triple Positive Cardiovascular Toxicity in a 76 yo male with NSCLC on Pembrolizumab Abstract
Poster
Case Challenge 37 Jose Alvarez-Cardona A multi-disciplinary approach for recurrent ventricular fibrillation and severe tricuspid regurgitation after mantle radiation for non-Hodgkin lymphoma Abstract
Poster
Case Challenge 38 Isabela Bispo Costa Cardiac Tamponade as the first manifestation of Erdheim-Chester Disease:  a rare case in literature Abstract
Poster
Case Challenge 40 Mahmoud Salem Surgical Resection for Cardiac Metastases of Uterine Leiomyosarcoma Abstract
Poster
Case Challenge 41 Robert Copeland-Halperin Severe Recurrent Pulmonary Arterial Hypertension from Bosutinib After Dasatinib Toxicity Abstract
Case Challenge 42 Emily Gosche Noninvasive Evaluation of a New Left Atrial Mass in a Patient with Prior Metastatic Germ Cell Tumor Abstract
Poster
Case Challenge 43 Alexa Perlick Dilated Cardiomyopathy due to Echovirus Abstract
Poster
Case Challenge 44 Stacy Sebastian A Case Report on the Use of Cardiac Troponins in Suspected Trastuzumab-Induced Cardiomyopathy During the Treatment of Metastatic Breast Cancer Abstract
Poster
Case Challenge 45 June-Wha Rhee Delayed development of marked aortitis following treatment with pembrolizumab in a patient with metastatic melanoma Abstract
Poster
Case Challenge 46 Katheryn Gambetta A Case of Crackles Abstract
Poster
Clinical Science 50 Yaser Khalid Cardiac Myxoma Tumor Dynamics-A Mathematical Monte Carlo Simulation as a Basis for Tumor Vaccine Abstract
Poster
Clinical Science 51 Yaser Khalid Radiation-Induced CAD: Gender Disparities for Patients with Hodgkin's Lymphoma Following Radiation Abstract
Poster
Clinical Science 52 Yaser Khalid Ibrutinib and the Underrecognized Risk Of Ventricular Tachycardia: A Metanalysis And Metaregression Abstract
Poster
Clinical Science 54 Christopher Malozzi Assessment of Cardiovascular Disease Risk Factor Control in Cancer Patients Abstract
Poster
Clinical Program 56 Rachel Barish Referral Patterns to a Cardio-Oncology Clinic Prior to Stem Cell Transplantation Abstract
Poster
Clinical Science 57 Cristina Bittar Coronary Computed Tomography Angiography in Combination with Coronary Artery Calcium Scoring for the Preoperative Cardiac Evaluation in cancer surgery Abstract
Poster
Clinical Science 58 Luke Joseph Incidence of Cancer Treatment Induced Arrhythmia Associated with Immune Checkpoint Inhibitors Abstract
Poster
Clinical Science 60 Sheela Krishnan Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma Abstract
Poster
Clinical Science 62 Toru Oka Impact of osimertinib on cardiac contractility in EGFR-mutated non-small cell lung cancer patients Abstract
Poster
Clinical Science 63 Courtney Campbell Delays in Diagnosis of Transthyretin Cardiac Amyloidosis after Establishing Cardiac Care Abstract
Poster
Clinical Science 64 Kerry Skurka 5-Fluorouracil Cardiac Toxicity: Insights from a Community-Based Cardio-Oncology Cohort Abstract
Poster
Clinical Science 65 Siddharth Chauhan FFR cost-effectively reduces mortality based upon malignancy type: Propensity score and machine learning supported nationally representative case-control study of over 30 million+ hospitalizations. Abstract
Poster
Clinical Science 66 Nicolas Palaskas Lack of Correlation between Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsy in Immune Checkpoint Inhibitor-Associated Myocarditis Abstract
Poster
Clinical Program 68 Niti Dham A Pediatric Cardiology-Oncology Program Abstract
Poster
Clinical Program 69 Isabela Bispo Costa 10 years of Brazilian Cardio-Oncology: the experience of Instituto do Cancer do Estado de Sao Paulo Abstract
Poster
Clinical Program 70 Courtney Campbell Untangling a Complex Web: Implementation of a Multidisciplinary Comprehensive Amyloidosis Clinic Abstract
Poster
Training and Education 72 Andre Gabriel Left Behind: The Cardio-Oncology Knowledge Gap among Primary Care Providers Abstract
Poster
Clinical Science 73 Sofia Kvernby T1- and T2-Mapping for Early Detection of Myocardial Changes in Breast Cancer Patients: Longitudinal Assessment during Radiation Therapy Abstract
Poster
Clinical Science 74 Dhiran Verghese Taking It To Heart- Clinical, Diagnostic and Pathologic Features of Immune-Checkpoint Inhibitor Induced Cardiotoxicity. Abstract
Poster
Clinical Science 75 Jonathan Mayl Incidence of Cardiotoxicity in Patient with Leukemia Being Treated with Tyrosine Kinase Inhibitors Abstract
Poster
Clinical Science 76 Zachary Brumberger Cardiotoxic Effects of Immune Checkpoint Inhibitors in 599 Patients Abstract
Poster
Case Challenge 77 Sanjay Chandrasekhar ST-Segment Elevation Myocardial Infarction in the Setting of Differentiation Syndrome Abstract
Poster
Case Challenge 78 Allison Padegimas Corticosteroid Refractory Immune Checkpoint Inhibitor Myocarditis Treated with Infliximab Abstract
Poster

Clinical Topics: Cardio-Oncology

Keywords: Cardiotoxicity